Some drug companies get to design their own studies, analyze the data, and control the publication of results. That’s too much power, according to the country’s top medical journals. Join us as we take a look at the controversy over drug-sponsored medical research.

Guests

  • Catherine DeAngelis MD, MPH, Editor in Chief The Journal of the American Medical Association, Member of International Committee of Medical Journal Editors
  • Susa Okie Medical repoer, "The Washinton Post."
  • Wayne Pines President of Healthcare and APCO; also former Commisioner, Food and Drug Administration.

Related Links

Topics + Tags

Most Recent Shows